From the Journals

Cannabis for sleep: Short-term benefit, long-term disruption?



Early days

Commenting on the findings in an interview, Ryan G. Vandrey, PhD, who was not involved in the study, said the findings are in line with previous research.

“I think the results make sense with respect to the data I’ve collected and from what I’ve seen,” said Dr. Vandrey, associate professor of psychiatry and behavioral sciences at Johns Hopkins Medicine in Baltimore.

“We typically only want to use sleep medications for short periods of time,” he continued. “When you think about recommended prescribing practices for any hypnotic medication, it’s usually short term, 2 weeks or less. Longer-term use often leads to tolerance, dependence, and withdrawal symptoms when the medication is stopped, which leads to an exacerbation of disordered sleep,” Dr. Vandrey said.

Nevertheless, he urged caution when interpreting the results.

“I think the study warrants caution about long-term daily use of cannabinoids with respect to sleep,” he said. “But we need more detailed evaluations, as the trial wasn’t testing a defined product, specific dose, or dose regimen.

“In addition, this was all done in the context of people with chronic pain and not treating disordered sleep or insomnia, but the study highlights the importance of recognizing that long-term chronic use of cannabis is not likely to fully resolve sleep problems.”

Dr. Sznitman agreed that the research is still in its very early stages.

“We’re still far from saying we have the evidence to support the use of medical cannabis for sleep,” she said. “For in the end it was just a cross-sectional, observational study, so we cannot say anything about cause and effect. But if these results pan out, they could be far-reaching and exciting.”

The study was funded by the University of Haifa and Rambam Hospital in Israel, and by the Evelyn Lipper Foundation. Dr. Sznitman and Dr. Vandrey have disclosed no relevant financial relationships.

This article first appeared on


Recommended Reading

Neurologists publish consensus statement on stridor in MSA
MDedge Neurology
High burden of mental health symptoms in teens with insomnia
MDedge Neurology
Insomnia symptoms increase likelihood of stroke and heart disease
MDedge Neurology
Mandatory OSA treatment for truckers lowers insurance costs
MDedge Neurology
Veterans at higher risk of sleep behavior disorders
MDedge Neurology
Reappraising standard treatment of comorbid insomnia/depression
MDedge Neurology
Novel analysis links insomnia to first-onset major depressive disorder
MDedge Neurology
FDA approves Dayvigo for insomnia
MDedge Neurology
Data point to bidirectional link between sleep disorders and ADHD
MDedge Neurology
Sleep problems linked to worsening PTSD in veterans
MDedge Neurology